|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Niax® Catalyst ESN | CAS 62765-93-9 | ||
|
|
RTECS QR3900000 | ||
|
Synonyms & Trade Names None [Note: A mixture of 95% dimethylaminopropionitrile & 5% bis(2-dimethylamino)ethyl ether.] |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: See Appendix C | ||
| OSHA PEL: See Appendix C | |||
| IDLH N.D. | Conversion | ||
|
Physical Description A liquid mixture. [Note: Used in the past as a catalyst in the manufacture of flexible polyurethane foams. |
|||
|
MW: mixture |
BP: ? |
FRZ: ? |
Sol: ? |
|
VP: ? |
IP: ? |
|
Sp.Gr: ? |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
|
Incompatibilities & Reactivities Oxidizers |
|||
|
Measurement Methods None available |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap flush immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin; urinary disturbance; neurological disorders; pins & needles in hands & feet; muscle weakness, lassitude (weakness, exhaustion), nausea, vomiting; decreased nerve conduction in lower legs | |
|
Target Organs
Eyes, skin, urinary tract, peripheral nervous system |
|
| See also: INTRODUCTION |